|
Á¢¼ö¹øÈ£ - 270325 11 |
CLINICAL MANIFESTATION OF HEARING LOSS AND COCHLEAR IMPLANTATION
PERFORMANCE IN DEAF PATIENTS WITH EVAS |
DEPARTMENT OF OTORHINOLARYNGOLOGY, ASAN MEDICAL CENTER, UNIVERSITY OF ULSAN COLLEGE OF MEDICINE, SEOUL, KOREA |
JI WON CHOI, SEUNG CHEOL HA, SANG HUN LEE, YEON JOO CHOI, WOO SEOK KANG, JOONG HO AHN, JONG WOO CHUNG, HONG JU PARK |
¸ñÀû: Enlarged vestibular aqueduct syndrome (EVAS) is the most common
congenital malformation of the inner ear and associated with
sensorineural or mixed hearing loss. Bilateral deafness,
progressive
hearing loss or sudden hearing loss is a clinical features of
patients
with EVAS. We aimed to classify the clinical features of EVAS and
evaluate their speech perception outcomes of Cochlear implants
(CI)
and compare to control group with normal structures ¹æ¹ý:A retrospective analysis was performed for 18 patients who were
diagnosed of EVAS and underwent CI surgery at Asan Medical
Center,
within the 5 year period (Those with EVA +IP II were excluded).
Control
group consisted of 85 CI patients with normal inner ear
structures.
Korean Standard monosyllabic word recognition score (KS-WRS) were
used
to evaluate the outcome after CI surgery.
°á°ú:The mean age of surgery for patients with EVAS was 3 years, and the age
of surgery for the normal structure group was 2.6 years. Of 18 EVAS who
underwent CI, 12 patients (66.6%) were deaf at birth, 6 patients (33.3%)
had progressive hearing impairment. There was no statistically
significant (p=0.199) difference in the mean Best score over five years
between patients with EVAS (60%) and the control group (69%). The mean
best score of patients deaf at birth (57%) was not significantly
different compared to the mean best score of those who have progressive
hearing impairment (64%). °á·Ð:This study showed that patients with EVAS still benefit from CI,
regardless of whether they were deaf at birth or had hearing
impairment. |
|